Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma

BACKGROUND: Transformation to small cell lung cancer (SCLC) is a resistance mechanism of epidermal growth factor receptor (EGFR) mutant lung adenocarcinoma (LADC) patients treated with EGFR tyrosine kinase inhibitors (TKIs). Here, we describe the clinical characteristics and prognosis of these patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shouzheng, Xie, Tongji, Hao, Xuezhi, Wang, Yan, Hu, Xingsheng, Wang, Lin, Li, Yan, Li, Junling, Xing, Puyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487822/
https://www.ncbi.nlm.nih.gov/pubmed/34490724
http://dx.doi.org/10.1111/1759-7714.14144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487822/
https://www.ncbi.nlm.nih.gov/pubmed/34490724
http://dx.doi.org/10.1111/1759-7714.14144

Ejemplares similares